
CAC2 Childhood Cancer Community News Digest (January 19-25)
Assorted News from the Last Week: Over the past year, CAC2 Supporting Organization Member LifeArc has hosted a series of twelve virtual workshops bringing together

Assorted News from the Last Week: Over the past year, CAC2 Supporting Organization Member LifeArc has hosted a series of twelve virtual workshops bringing together

Assorted News from the Last Week: ARPA-H announced $50 million to expand pediatric care across the country for patients with complex medical diseases. The program–Pediatric

Assorted News from the Last Week: Two articles of interest about childhood and AYA cancer survivorship: Microvascular skeletal muscle oxygenation linked to exercise capacity in

Assorted News from the Last Week: Accelerated brain aging, atherogenicity, and neurocognition in adult survivors of childhood cancer. The FDA has approved narsoplimab-wuug (Yartemlea) for

Assorted News from the Last Week: Study reveals the profound psychological burden borne not only by childhood cancer survivors but also by their parents, including

Assorted News from the Last Week: CAC2 Board Member Aubrey Reichard-Eline of WITH Grace Initiatives pens powerful Op Ed: “Turning pain into purpose: how service

Assorted News from the Last Week: CAC2 Member Braden’s Hope for Childhood Cancer funds new program to help childhood cancer survivors as they enter adulthood.

Assorted News from the Last Week: American Association for Cancer Research released the AACR Pediatric Cancer Progress Report 2025. Among the trends highlighted: Between 2015 and

Assorted News from the Last Week: Drug combination sidesteps resistance in aggressive childhood neuroblastoma models. Study results suggest that apatinib plus IE may improve PFS

Assorted News from the Last Week: This edition of the CAC2 blog post provides a compassionate guide to embracing bereaved families during the holidays. Columbia